Sutherland BA - Search Results

1

Rapamycin in ischemic stroke: Old drug, new tricks?

Hadley G, Beard DJ, Couch Y, Neuhaus AA, Adriaanse BA, DeLuca GC, Sutherland BA, Buchan AM. Hadley G, et al. Among authors: sutherland ba. J Cereb Blood Flow Metab. 2019 Jan;39(1):20-35. doi: 10.1177/0271678X18807309. Epub 2018 Oct 18. J Cereb Blood Flow Metab. 2019. PMID: 30334673 Free PMC article. Review.

2

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.

Harston GW, Sutherland BA, Kennedy J, Buchan AM. Harston GW, et al. Among authors: sutherland ba. J Cereb Blood Flow Metab. 2010 Nov;30(11):1804-16. doi: 10.1038/jcbfm.2010.149. Epub 2010 Aug 25. J Cereb Blood Flow Metab. 2010. PMID: 20736961 Free PMC article. Review.

3

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.

Sutherland BA, Papadakis M, Chen RL, Buchan AM. Sutherland BA, et al. J Physiol. 2011 Sep 1;589(17):4105-14. doi: 10.1113/jphysiol.2011.209601. Epub 2011 Jun 27. J Physiol. 2011. PMID: 21708904 Free PMC article.

4

Neuroprotection for ischaemic stroke: translation from the bench to the bedside.

Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Sutherland BA, et al. Int J Stroke. 2012 Jul;7(5):407-18. doi: 10.1111/j.1747-4949.2012.00770.x. Epub 2012 Mar 6. Int J Stroke. 2012. PMID: 22394615 Review.

5

Neuroprotection for stroke: current status and future perspectives.

Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Minnerup J, et al. Among authors: sutherland ba. Int J Mol Sci. 2012;13(9):11753-11772. doi: 10.3390/ijms130911753. Epub 2012 Sep 18. Int J Mol Sci. 2012. PMID: 23109881 Free PMC article. Review.

6

Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future.

Balami JS, Chen R, Sutherland BA, Buchan AM. Balami JS, et al. Among authors: sutherland ba. CNS Neurol Disord Drug Targets. 2013 Mar;12(2):145-54. doi: 10.2174/18715273113129990057. CNS Neurol Disord Drug Targets. 2013. PMID: 23394531 Review.

7

Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.

Balami JS, Sutherland BA, Buchan AM. Balami JS, et al. Among authors: sutherland ba. CNS Neurol Disord Drug Targets. 2013 Mar;12(2):155-69. doi: 10.2174/18715273112119990050. CNS Neurol Disord Drug Targets. 2013. PMID: 23394532 Review.

8

Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat.

Sutherland BA, Buchan AM. Sutherland BA, et al. J Cereb Blood Flow Metab. 2013 Nov;33(11):e1-7. doi: 10.1038/jcbfm.2013.148. Epub 2013 Aug 21. J Cereb Blood Flow Metab. 2013. PMID: 23963368 Free PMC article.

9

The exact science of stroke thrombolysis and the quiet art of patient selection.

Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Balami JS, et al. Among authors: sutherland ba. Brain. 2013 Dec;136(Pt 12):3528-53. doi: 10.1093/brain/awt201. Epub 2013 Sep 14. Brain. 2013. PMID: 24038074 Review.

10

Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation.

Redzic ZB, Rabie T, Sutherland BA, Buchan AM. Redzic ZB, et al. Among authors: sutherland ba. Int J Stroke. 2015 Apr;10(3):407-14. doi: 10.1111/ijs.12197. Epub 2013 Nov 10. Int J Stroke. 2015. PMID: 24206924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters